Volitionrx (VNRX) Operating Margin (2012 - 2025)
Volitionrx (VNRX) posted Operating Margin of 1329.65% for Q4 2025, down 63.51% on a QoQ basis from 813.2% in Q3 2025, and up 351916.0% year-over-year from N/an in Q4 2024.
Volitionrx (VNRX) Operating Margin (2012 - 2025) Analysis & Trends
Volitionrx's Operating Margin history runs 8 years deep, the most recent figure standing at 1329.65% for Q4 2025.
- Quarterly Operating Margin rose 351916.0% year-over-year to 1329.65% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1467.9% (up 130781.0% YoY) and the FY2025 annual result came in at 1702.88%, up 98518.0% from the prior year.
- Operating Margin was 1329.65% for Q4 2025 at Volitionrx, down from 813.2% in the prior quarter.
- Across five years, Operating Margin topped out at 7957.03% in Q4 2022 and bottomed at 61692.56% in Q4 2021.
- A 5-year average of 12473.94% and a median of 5617.36% in 2023 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2021 — Operating Margin soared 105555788 bps — and 2023, when it tumbled 2097779 bps.
- Volitionrx's Operating Margin stood at 61692.56% in 2021, then jumped by 113 bps to 7957.03% in 2022, then slumped by 264 bps to 13020.76% in 2023, then soared by 63 bps to 4848.82% in 2024, then jumped by 73 bps to 1329.65% in 2025.
- Business Quant data shows VNRX's Operating Margin at 1329.65% in Q4 2025, 813.2% in Q3 2025, and 2571.48% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | -1,329.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,329.65% |
| Sep 30, 2025 | -813.20% |
| Jun 30, 2025 | -2,571.48% |
| Mar 31, 2025 | -2,241.09% |
| Dec 31, 2024 | -4,848.82% |
| Sep 30, 2024 | -1,445.18% |
| Jun 30, 2024 | -2,499.19% |
| Mar 31, 2024 | -4,973.10% |
| Dec 31, 2023 | -13,020.76% |
| Sep 30, 2023 | -6,785.49% |
| Jun 30, 2023 | -4,414.51% |
| Mar 31, 2023 | -6,261.62% |
| Dec 31, 2022 | 7,957.03% |
| Sep 30, 2022 | -40,121.25% |
| Jun 30, 2022 | -20,375.01% |
| Mar 31, 2022 | -6,721.75% |
| Dec 31, 2021 | -61,692.56% |
| Sep 30, 2021 | -29,675.83% |
| Jun 30, 2021 | -23,810.25% |
| Mar 31, 2021 | -23,835.14% |